Magnetic resonance imaging of experimental atherosclerotic plaque: Comparison of two ultrasmall superparamagnetic particles of iron oxide

被引:48
|
作者
Herborn, Christoph U.
Vogt, Florian M.
Lauenstein, Thomas C.
Dirsch, Olaf
Corot, Claire
Robert, Philippe
Ruehm, Stefan G.
机构
[1] Univ Hamburg, Med Ctr, Med Prevent Ctr, D-20251 Hamburg, Germany
[2] Univ Hosp Essen, Dept Diagnost & Intervent Radiol, Essen, Germany
[3] Lab Guerbet, Aulnay Sous Bois, France
[4] Univ Hosp Essen, Dept Pathol, Essen, Germany
[5] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, Los Angeles, CA USA
[6] Emory Univ, Sch Med, Dept Radiol, Atlanta, GA USA
关键词
atherosclerosis; magnetic resonance imaging; contrast media; USPIO; animal model;
D O I
10.1002/jmri.20649
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To evaluate a new ultrasmall superparamagnetic particles of iron oxide (USPIO) compound, ferumoxytol, as a marker of macrophage activity in atherosclerotic plaques and to compare it to ferumoxtran-10. Materials and Methods: Ten mature heritable hyperlipidemic (WHHL) female Watanabe rabbits served as the animal model for atherosclerosis, four coeval female New Zealand White (NZW) rabbits were the control group. Five WHHL and two NZW received a single intravenous injection (250 mu mol/kg) of either ferumoxtran-10 or ferumoxytol and were subjected to daily-MR examinations on a 1.5T. whole body scanner for the next five days. Development of signal intensity changes and susceptibility effects was assessed. Statistical analysis was based on a nonparametric Wilcoxon-Mann-Whitney-U test, by using a P value at the 0.05 significance level. On day 5, the rabbits were sacrificed and the aorta was referred to histopathology, distribution of iron particles in the vessel wall was analyzed. Results: MRI was feasible in all animals. Three days after injection of ferumoxytol the highest luminal signal,intensity measurements were observed in the ferumoxytol group; the highest measurements were five days after injection in the ferumoxtran- 10 group, (P < 0.05). In the WHHL, susceptibility effects presented as homogeneous dark lines parallel to the aortic wall after ferumoxytol and spotted areas void of signal after ferumoxtran-10. None of these findings were observed in. the NZW control groups.
引用
收藏
页码:388 / 393
页数:6
相关论文
共 50 条
  • [41] Microcirculation of intramyocardial hemorrhage caused by reperfused myocardial infarctions with ultrasmall superparamagnetic iron oxide cardiac magnetic resonance imaging
    Xia, Rui
    Zhu, Tong
    Zhang, Yu
    He, Bo
    Wang, Lei
    Zheng, Jie
    Gao, Fabao
    ACTA RADIOLOGICA, 2022, 63 (11) : 1469 - 1474
  • [42] Detection of atherosclerotic plaque with gadofluorine-enhanced magnetic resonance imaging
    Barkhausen, J
    Ebert, W
    Heyer, C
    Debatin, JF
    Weinmann, HJ
    CIRCULATION, 2003, 108 (05) : 605 - 609
  • [43] Comparison of Contrast Agents for Atherosclerosis Imaging Using Cultured Macrophages: FDG Versus Ultrasmall Superparamagnetic Iron Oxide
    Satomi, Tomoko
    Ogawa, Mikako
    Mori, Ikuo
    Ishino, Seigo
    Kubo, Kazuki
    Magata, Yasuhiro
    Nishimoto, Tomoyuki
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (06) : 999 - 1004
  • [44] Evaluation of lymph node metastases of breast cancer using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging
    Harada, Tomoaki
    Tanigawa, Nobuhiko
    Matsuki, Mitsuru
    Nohara, Takehiro
    Narabayashi, Isamu
    EUROPEAN JOURNAL OF RADIOLOGY, 2007, 63 (03) : 401 - 407
  • [45] Biocompatible Peptide-Coated Ultrasmall Superparamagnetic Iron Oxide Nanoparticles for In Vivo Contrast-Enhanced Magnetic Resonance Imaging
    Chee, Heng Li
    Gan, Ching Ruey R.
    Ng, Michael
    Low, Lionel
    Fernig, David G.
    Bhakoo, Kishore K.
    Paramelle, David
    ACS NANO, 2018, 12 (07) : 6480 - 6491
  • [46] Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque
    Kerwin, W
    Hooker, A
    Spilker, M
    Vicini, P
    Ferguson, M
    Hatsukami, T
    Yuan, C
    CIRCULATION, 2003, 107 (06) : 851 - 856
  • [47] Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent
    Bourrinet, P
    Bengele, HH
    Bonnemain, B
    Dencausse, A
    Idee, JM
    Jacobs, PM
    Lewis, JM
    INVESTIGATIVE RADIOLOGY, 2006, 41 (03) : 313 - 324
  • [48] Delineation and characterization of atherosclerotic plaque lesions by magnetic resonance imaging
    Loewe, C
    Oberhuber, G
    Loewe, R
    Frank, H
    ZEITSCHRIFT FUR KARDIOLOGIE, 1998, 87 (08): : 622 - 629
  • [49] Specific targeting of nasopharyngeal carcinoma cell line CNE1 by C225-conjugated ultrasmall superparamagnetic iron oxide particles with magnetic resonance imaging
    Liu, Dongbo
    Chen, Chunli
    Hu, Guangyuan
    Mei, Qi
    Qiu, Hong
    Long, Guoxian
    Hu, Guoqing
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2011, 43 (04) : 301 - 306
  • [50] Characterisation of carotid atherosclerotic plaque: comparison between magnetic resonance imaging and histology
    Puppini, G.
    Furlan, F.
    Cirota, N.
    Veraldi, G.
    Piubello, Q.
    Montemezzi, S.
    Gortenuti, G.
    RADIOLOGIA MEDICA, 2006, 111 (07): : 921 - 930